388 related articles for article (PubMed ID: 27070090)
1. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.
Kowalik MA; Guzzo G; Morandi A; Perra A; Menegon S; Masgras I; Trevisan E; Angioni MM; Fornari F; Quagliata L; Ledda-Columbano GM; Gramantieri L; Terracciano L; Giordano S; Chiarugi P; Rasola A; Columbano A
Oncotarget; 2016 May; 7(22):32375-93. PubMed ID: 27070090
[TBL] [Abstract][Full Text] [Related]
2. Clear cell hepatocellular carcinoma: origin, metabolic traits and fate of glycogenotic clear and ground glass cells.
Bannasch P; Ribback S; Su Q; Mayer D
Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):570-594. PubMed ID: 29291777
[TBL] [Abstract][Full Text] [Related]
3. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC).
Petrelli A; Perra A; Cora D; Sulas P; Menegon S; Manca C; Migliore C; Kowalik MA; Ledda-Columbano GM; Giordano S; Columbano A
Hepatology; 2014 Jan; 59(1):228-41. PubMed ID: 23857252
[TBL] [Abstract][Full Text] [Related]
5. The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer.
Barajas JM; Reyes R; Guerrero MJ; Jacob ST; Motiwala T; Ghoshal K
Sci Rep; 2018 Jun; 8(1):9105. PubMed ID: 29904144
[TBL] [Abstract][Full Text] [Related]
6. PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis.
Hong X; Song R; Song H; Zheng T; Wang J; Liang Y; Qi S; Lu Z; Song X; Jiang H; Liu L; Zhang Z
Gut; 2014 Oct; 63(10):1635-47. PubMed ID: 24352616
[TBL] [Abstract][Full Text] [Related]
7. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.
Coda DM; Lingua MF; Morena D; Foglizzo V; Bersani F; Ala U; Ponzetto C; Taulli R
Cell Cycle; 2015; 14(9):1389-402. PubMed ID: 25644430
[TBL] [Abstract][Full Text] [Related]
8. Elevated G6PD expression contributes to migration and invasion of hepatocellular carcinoma cells by inducing epithelial-mesenchymal transition.
Lu M; Lu L; Dong Q; Yu G; Chen J; Qin L; Wang L; Zhu W; Jia H
Acta Biochim Biophys Sin (Shanghai); 2018 Apr; 50(4):370-380. PubMed ID: 29471502
[TBL] [Abstract][Full Text] [Related]
9. Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways.
Li M; He X; Guo W; Yu H; Zhang S; Wang N; Liu G; Sa R; Shen X; Jiang Y; Tang Y; Zhuo Y; Yin C; Tu Q; Li N; Nie X; Li Y; Hu Z; Zhu H; Ding J; Li Z; Liu T; Zhang F; Zhou H; Li S; Yue J; Yan Z; Cheng S; Tao Y; Yin H
Nat Cancer; 2020 Jul; 1(7):735-747. PubMed ID: 35122041
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma.
Yao DF; Jiang H; Yao M; Li YM; Gu WJ; Shen YC; Qiu LW; Wu W; Wu XH; Sai WL
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):407-13. PubMed ID: 19666411
[TBL] [Abstract][Full Text] [Related]
11. Frequent alteration of the protein synthesis of enzymes for glucose metabolism in hepatocellular carcinomas.
Shimizu T; Inoue K; Hachiya H; Shibuya N; Shimoda M; Kubota K
J Gastroenterol; 2014 Sep; 49(9):1324-32. PubMed ID: 24203292
[TBL] [Abstract][Full Text] [Related]
12. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
[TBL] [Abstract][Full Text] [Related]
14. [Molecular and metabolic changes in human clear cell liver foci].
Ribback S; Calvisi DF; Cigliano A; Rausch J; Heidecke CD; Birth M; Dombrowski F
Pathologe; 2015 Nov; 36 Suppl 2():210-5. PubMed ID: 26483250
[TBL] [Abstract][Full Text] [Related]
15. Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells.
Hu H; Ding X; Yang Y; Zhang H; Li H; Tong S; An X; Zhong Q; Liu X; Ma L; Liu Q; Liu B; Lu Z; Zhang D; Hu P; Ren H
Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(6):G611-22. PubMed ID: 24994855
[TBL] [Abstract][Full Text] [Related]
16. Induction of autophagy promotes the growth of early preneoplastic rat liver nodules.
Kowalik MA; Perra A; Ledda-Columbano GM; Ippolito G; Piacentini M; Columbano A; Falasca L
Oncotarget; 2016 Feb; 7(5):5788-99. PubMed ID: 26735341
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.
Zhang S; Nguyen LH; Zhou K; Tu HC; Sehgal A; Nassour I; Li L; Gopal P; Goodman J; Singal AG; Yopp A; Zhang Y; Siegwart DJ; Zhu H
Gastroenterology; 2018 Apr; 154(5):1421-1434. PubMed ID: 29274368
[TBL] [Abstract][Full Text] [Related]
18. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver.
van Hengel J; D'Hooge P; Hooghe B; Wu X; Libbrecht L; De Vos R; Quondamatteo F; Klempt M; Brakebusch C; van Roy F
Gastroenterology; 2008 Mar; 134(3):781-92. PubMed ID: 18325391
[TBL] [Abstract][Full Text] [Related]
19. Methylated chrysin induces co-ordinated attenuation of the canonical Wnt and NF-kB signaling pathway and upregulates apoptotic gene expression in the early hepatocarcinogenesis rat model.
Khan MS; Halagowder D; Devaraj SN
Chem Biol Interact; 2011 Aug; 193(1):12-21. PubMed ID: 21554863
[TBL] [Abstract][Full Text] [Related]
20. Interferon-microRNA signalling drives liver precancerous lesion formation and hepatocarcinogenesis.
Yang Y; Lin X; Lu X; Luo G; Zeng T; Tang J; Jiang F; Li L; Cui X; Huang W; Hou G; Chen X; Ouyang Q; Tang S; Sun H; Chen L; Gonzalez FJ; Wu M; Cong W; Chen L; Wang H
Gut; 2016 Jul; 65(7):1186-201. PubMed ID: 26860770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
